Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

1986 • 454 citations

Phase I clinical and pharmacokinetic study of taxol.

1987 • 449 citations

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1987 • 286 citations

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

1989 • 196 citations

Phase I trial of taxol in patients with advanced cancer.

1987 • 180 citations

The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.

1987 • 77 citations

The influence of information on drug resistance on protocol design

1991 • 26 citations

Changing concepts in the management of epithelial ovarian and cervical cancers

1988 • 6 citations